BACKGROUND: Adiponectin plays a protective role in the development of obesity-linked disorders. We demonstrated that adiponectin exerts beneficial actions on acute ischemic injury in mice hearts. However, the effects of adiponectin treatment in large animals and its feasibility in clinical practice have not been investigated. This study investigated the effects of intracoronary administration of adiponectin on myocardial ischemia-reperfusion (I/R) injury in pigs. METHODS AND RESULTS: The left anterior descending coronary artery was occluded in pigs for 45 minutes and then reperfused for 24 hours. Recombinant adiponectin protein was given as a bolus intracoronary injection during ischemia. Cardiac functional parameters were measured by a manometer-tipped catheter. Apoptosis was evaluated by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling staining. Tumor necrosis factor-alpha and interleukin-10 transcripts were analyzed by real-time polymerase chain reaction. Serum levels of derivatives of reactive oxygen metabolites and biological antioxidant potential were measured. Adiponectin protein was determined by immunohistochemical and Western blot analyses. Intracoronary administration of adiponectin protein led to a reduction in myocardial infarct size and improvement of left ventricular function in pigs after I/R. Injected adiponectin protein accumulated in the I/R-injured heart. Adiponectin treatment resulted in decreased tumor necrosis factor-alpha and increased interleukin-10 mRNA levels in the myocardium after I/R. Adiponectin-treated pigs had reduced apoptotic activity in the I/R-injured heart and showed increased biological antioxidant potential levels and decreased derivatives of reactive oxygen metabolite levels in the blood stream after I/R. CONCLUSIONS: These data suggest that adiponectin protects against I/R injury in a preclinical pig model through its ability to suppress inflammation, apoptosis, and oxidative stress. Administration of intracoronary adiponectin could be a useful adjunctive therapy for acute myocardial infarction.
BACKGROUND:Adiponectin plays a protective role in the development of obesity-linked disorders. We demonstrated that adiponectin exerts beneficial actions on acute ischemic injury in mice hearts. However, the effects of adiponectin treatment in large animals and its feasibility in clinical practice have not been investigated. This study investigated the effects of intracoronary administration of adiponectin on myocardial ischemia-reperfusion (I/R) injury in pigs. METHODS AND RESULTS: The left anterior descending coronary artery was occluded in pigs for 45 minutes and then reperfused for 24 hours. Recombinant adiponectin protein was given as a bolus intracoronary injection during ischemia. Cardiac functional parameters were measured by a manometer-tipped catheter. Apoptosis was evaluated by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling staining. Tumor necrosis factor-alpha and interleukin-10 transcripts were analyzed by real-time polymerase chain reaction. Serum levels of derivatives of reactive oxygen metabolites and biological antioxidant potential were measured. Adiponectin protein was determined by immunohistochemical and Western blot analyses. Intracoronary administration of adiponectin protein led to a reduction in myocardial infarct size and improvement of left ventricular function in pigs after I/R. Injected adiponectin protein accumulated in the I/R-injured heart. Adiponectin treatment resulted in decreased tumor necrosis factor-alpha and increased interleukin-10 mRNA levels in the myocardium after I/R. Adiponectin-treated pigs had reduced apoptotic activity in the I/R-injured heart and showed increased biological antioxidant potential levels and decreased derivatives of reactive oxygen metabolite levels in the blood stream after I/R. CONCLUSIONS: These data suggest that adiponectin protects against I/R injury in a preclinical pig model through its ability to suppress inflammation, apoptosis, and oxidative stress. Administration of intracoronary adiponectin could be a useful adjunctive therapy for acute myocardial infarction.
Authors: Subodh Verma; Paul W M Fedak; Richard D Weisel; Jagdish Butany; Vivek Rao; Andrew Maitland; Ren-Ke Li; Bikramjit Dhillon; Terrence M Yau Journal: Circulation Date: 2002-05-21 Impact factor: 29.690
Authors: S Kojima; T Funahashi; T Sakamoto; S Miyamoto; H Soejima; J Hokamaki; I Kajiwara; S Sugiyama; M Yoshimura; K Fujimoto; Y Miyao; H Suefuji; A Kitagawa; N Ouchi; S Kihara; Y Matsuzawa; H Ogawa Journal: Heart Date: 2003-06 Impact factor: 5.994
Authors: Y Okamoto; Y Arita; M Nishida; M Muraguchi; N Ouchi; M Takahashi; T Igura; Y Inui; S Kihara; T Nakamura; S Yamashita; J Miyagawa; T Funahashi; Y Matsuzawa Journal: Horm Metab Res Date: 2000-02 Impact factor: 2.936
Authors: Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh Journal: Nat Med Date: 2004-11-21 Impact factor: 53.440
Authors: Koichi Inagaki; Leon Chen; Fumiaki Ikeno; Felix H Lee; Ken-ichi Imahashi; Donna M Bouley; Mehrdad Rezaee; Paul G Yock; Elizabeth Murphy; Daria Mochly-Rosen Journal: Circulation Date: 2003-11-03 Impact factor: 29.690
Authors: Komei Tanaka; Richard M Wilson; Eric E Essick; Jennifer L Duffen; Philipp E Scherer; Noriyuki Ouchi; Flora Sam Journal: Circ Heart Fail Date: 2014-08-22 Impact factor: 8.790
Authors: Nanette J Tomicek; J Craig Hunter; Alexandra M Machikas; Veronica Lopez; Donna H Korzick Journal: Geriatr Gerontol Int Date: 2014-08-13 Impact factor: 2.730